Gabapentin Capsule
Product Images NDC 42385-973

22 FDA label images from Laurus Labs Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42385-973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Gabapentin Structure)

Structure (Gabapentin Structure)
Chemical structure of Gabapentin showing the arrangement of atoms including an amine group (NH2) and a carboxylic acid group (COOH) attached to a cyclohexane ring.*
FDA Label Image

Gabapentin-figure1.jpg (Gabapentin Figure1)

Gabapentin-figure1.jpg (Gabapentin Figure1)
A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The X-axis represents weeks, including a baseline, and is divided into a 4-week dose titration period and a 4-week fixed dose period. The Y-axis displays mean pain scores from 0 to 10. Gabapentin shows a decreasing mean pain score trend, while placebo remains relatively stable.*
FDA Label Image

Gabapentin-figure2.jpg (Gabapentin Figure2)

Gabapentin-figure2.jpg (Gabapentin Figure2)
A line graph showing mean pain scores over 7 weeks during a clinical study period, comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The X-axis represents weeks, and the Y-axis shows mean pain scores ranging from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*
FDA Label Image

Gabapentin-figure3 (Gabapentin Figure3)

Gabapentin-figure3 (Gabapentin Figure3)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' illustrating results from two studies comparing placebo (PBO) and gabapentin (GBP) at various dosages (3600 mg, 1800 mg, 2400 mg). The chart shows responder percentages on the y-axis up to 100%, with gabapentin bars significantly higher than placebo in both studies.*
FDA Label Image

Gabapentin-figure4 (Gabapentin Figure4)

Gabapentin-figure4 (Gabapentin Figure4)
A scatter plot graph showing the percentage difference versus daily dose in milligrams (mg) for Gabapentin from three studies labeled a, b, and c. The daily doses range from around 600 mg to 1800 mg, with percentage difference values plotted along the vertical axis. Each study is represented by different colored squares: black for Study a, gray for Study b, and white for Study c.*
FDA Label Image

Gabapentin-figure14 (Gabapentin Figure14)

Gabapentin-figure14 (Gabapentin Figure14)
A text panel listing potential side effects or symptoms to watch for, including shortness of breath, slowed breathing, extreme tiredness, confusion, dizziness, and headache. The content appears as a bulleted list of symptoms without further medical context.*
FDA Label Image

Gabapentin-figure15 (Gabapentin Figure15)

Gabapentin-figure15 (Gabapentin Figure15)
Text panel listing side effects or symptoms related to a medication, including lack of coordination, viral infection, difficulty speaking, tremor, swelling of legs and feet, tiredness, fever, drowsiness, nausea and vomiting, jerky movements, difficulty with coordination, double vision, and unusual eye movement.*
FDA Label Image

Gabapentin-figure5.jpg (Gabapentin Figure5)

Gabapentin-figure5.jpg (Gabapentin Figure5)
Label for Gabapentin Capsules, USP 100 mg, manufactured by Laurus Labs Limited and Laurus Generics Inc. The label includes dispensing instructions, storage conditions, and packaging details indicating 30 capsules per container. It shows the NDC number 42385-972-30 and manufacturer addresses in India and New Jersey.*
FDA Label Image

Figure-6 (Gabapentin Figure6)

Figure-6 (Gabapentin Figure6)
Label sheet for Gabapentin Capsule, USP 100 mg by Laurus Labs Limited. The sheet contains multiple identical labels, each showing the product name, strength (100 mg), route (capsule), Rx only notation, barcode, manufacturer, and placeholders for lot and expiration date. NDC 42385-972-17 is printed on each label.*
FDA Label Image

Gabapentin-figure7.jpg (Gabapentin Figure7)

Gabapentin-figure7.jpg (Gabapentin Figure7)
Gabapentin Capsules, USP 100 mg unit-dose capsules carton for institutional use only. The package contains 100 capsules (10 x 10) and is labeled for dispensing the enclosed medication guide to each patient. Manufactured by Laurus Labs Limited and labeled by Laurus Generics Inc. The label includes storage instructions and a barcode.*
FDA Label Image

Gabapentin-figure8.jpg (Gabapentin Figure8)

Gabapentin-figure8.jpg (Gabapentin Figure8)
Label for Gabapentin Capsules, USP 300 mg, showing package quantity of 30 capsules. The label includes storage instructions, manufacturer Laurus Labs Limited, and distributor Laurus Generics Inc. It displays the NDC 42385-973-30 and advises dispensing the enclosed medication guide to each patient.*
FDA Label Image

Figure9 (Gabapentin Figure9)

Figure9 (Gabapentin Figure9)
Label sheet for Gabapentin Capsule, USP 300 mg by Laurus Labs Limited. The label includes multiple identical rectangular sections each stating "Rx only" with NDC 42385-973-17, the product name Gabapentin Capsule, USP, strength 300 mg in bold on a black background, manufacturer Laurus Labs Limited, and fields for lot and expiration dates. Each section features a barcode. The layout suggests these labels are for individual capsules or bottles.*
FDA Label Image

Gabapentin-figure10.jpg (Gabapentin Figure10)

Gabapentin-figure10.jpg (Gabapentin Figure10)
Gabapentin Capsules USP 300 mg packaging label for oral capsules. The label indicates 100 unit-dose capsules in the package, manufactured by Laurus Labs Limited and labeled for Laurus Generics Inc. It includes storage instructions and a medication guide notice. The label uses black text with purple highlights for the strength.*
FDA Label Image

Gabapentin-figure11.jpg (Gabapentin Figure11)

Gabapentin-figure11.jpg (Gabapentin Figure11)
Label for Gabapentin Capsules, USP 400 mg, in a 30-capsule bottle. Manufactured by Laurus Labs Limited and labeled for Laurus Generics Inc. The label includes storage instructions, dispensing guidelines, and a barcode. The product is prescription only.*
FDA Label Image

Figure-12 (Gabapentin Figure12)

Figure-12 (Gabapentin Figure12)
Label sheet for Gabapentin Capsule, USP 400 mg, showing multiple identical dose labels. Each label includes the product name, strength (400 mg), 'Rx only' indication, NDC 42385-974-17, manufacturer Laurus Labs Limited, and areas for lot number and expiration date. Barcodes appear on each label.*
FDA Label Image

Gabapentin-figure13.jpg (Gabapentin Figure13)

Gabapentin-figure13.jpg (Gabapentin Figure13)
Gabapentin Capsules, USP 400 mg blister carton label for 100 unit-dose capsules. The label includes dosage strength, manufacturer Laurus Labs Limited, and distributor Laurus Generics Inc. It instructs to dispense the enclosed Medication Guide and notes storage conditions. The label displays the NDC 42385-974-72 and barcode.*
FDA Label Image

Gabapentin-figure16.jpg (Gabapentin Figure16)

Gabapentin-figure16.jpg (Gabapentin Figure16)
Gabapentin Tablets USP 600 mg label showing tablet strength and form, manufactured by Laurus Labs Limited, with packaging details including storage instructions, quantity of 30 tablets, and NDC 42385-979-30. The label includes manufacturer and distributor information and a barcode.*
FDA Label Image

Gabapentin-figure17 (Gabapentin Figure17)

Gabapentin-figure17 (Gabapentin Figure17)
Sheet of ten identical labels for Gabapentin Tablet, USP 600 mg. Each label states Rx only, includes NDC 42385-979-17, manufacturer Laurus Labs Limited, and features a barcode. Lot and expiration fields are blank. The layout is in two columns and five rows with pink borders.*
FDA Label Image

Gabapentin-figure18.jpg (Gabapentin Figure18)

Gabapentin-figure18.jpg (Gabapentin Figure18)
Gabapentin Tablets, USP 600 mg carton label for unit-dose tablets. The label indicates 100 tablets (10 packs of 10), with dosing and storage instructions. Manufactured by Laurus Labs Limited, India, for Laurus Generics Inc. The label includes a medication guide URL and states the product is Rx only for institutional use.*
FDA Label Image

Gabapentin-figure19.jpg (Gabapentin Figure19)

Gabapentin-figure19.jpg (Gabapentin Figure19)
Label for Gabapentin Tablets USP, 800 mg strength, provided in a bottle of 30 tablets. The label states the product contains 800 mg gabapentin per tablet, is for oral use, and is manufactured by Laurus Labs Limited, India, for Laurus Generics Inc., NJ. It includes storage instructions and a website link for the medication guide.*
FDA Label Image

Gabapentin-figure20 (Gabapentin Figure20)

Gabapentin-figure20 (Gabapentin Figure20)
Multiple unit labels for Gabapentin Tablet, USP 800 mg. Each label includes the NDC 42385-980-17, states "Rx only," and notes manufacturing by Laurus Labs Limited. The labels also include space for lot and expiration dates along with a barcode on the right side. These labels appear arranged in a grid for printing.*
FDA Label Image

Gabapentin-figure21.jpg (Gabapentin Figure21)

Gabapentin-figure21.jpg (Gabapentin Figure21)
Box label for Gabapentin Tablets, USP 800 mg, manufactured by Laurus Labs Limited. The packaging states 100 unit-dose tablets (10 x 10) for institutional use only and Rx only. Includes storage instructions and a Medication Guide URL. The labeler is Laurus Generics Inc., Berkeley Heights, NJ, with manufacturing in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.